Förfarande för framställning av farmakologiskt aktiva etylendiaminmono amidderivat

摘要

Compounds of the formula I wherein R is an aromatic, 5- or 6-membered heterocyclic residue, as described herein, and their pharmaceutically usable acid addition salts are described. These compounds have interesting monoamine oxidase inhibiting properties with low toxicity and can accordingly be used for the treatment of depressive states and parkinsonism.